Cargando…
Potential interactions between antineoplastic agents and medicines used to treat Covid-19
INTRODUCTION: Cancer patients with Covid-19 are exposed to treatment combinations that can potentially result in interactions that adversely affect patient outcomes. This study aimed to identify potential drug–drug interactions between antineoplastic agents and medicines used to treat Covid-19. METH...
Autores principales: | Sobreira da Silva, Mario Jorge, Serpa Osorio-de-Castro, Claudia Garcia, Paes, Rafael Duarte, Negrete, Christopher Lucas, Eugênio, Elizangela, Moraes, Elaine Lazzaroni, Livinalli, Annemeri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619075/ https://www.ncbi.nlm.nih.gov/pubmed/34637360 http://dx.doi.org/10.1177/10781552211040494 |
Ejemplares similares
-
First use of antineoplastic agents in women with breast cancer in the state of Rio de Janeiro, Brazil
por: dos Santos, Ranailla Lima Bandeira, et al.
Publicado: (2023) -
Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer
por: Livinalli, Annemeri, et al.
Publicado: (2019) -
Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019
por: dos Santos, Ranailla Lima Bandeira, et al.
Publicado: (2022) -
Cancer care in Brazil: structure and geographical distribution
por: da Silva, Mario Jorge Sobreira, et al.
Publicado: (2019) -
Antineoplastic and Immunosuppressive Agents—Part 1
por: Lajtha, L. G.
Publicado: (1975)